In a plot twist more dramatic than an iPhone launch, Apple is hitting the pause button on sales for its Series 9 and Ultra 2 Apple Watches in the U.S.
Why? Glad you asked. Well, it turns out the cool blood oxygen sensor, the heartbeat of Apple’s smartwatches, has caused a not-so-healthy legal commotion. Medical tech company Masimo claims Apple swiped their tech, and a jury couldn’t decide if Apple was the copycat or not. It’s the courtroom saga you never knew you needed.
To add a sprinkle of holiday cheer, Apple decided to remove the watches from shelves just before Christmas. Someone didn’t get the memo that ’tis the season to be jolly, not embroiled in patent disputes. In other news, Masimo, feeling like the hero of the story, cheers on from the sidelines, declaring, “Even the world’s most powerful company must abide by the law.”
Imagine the Apple execs scrambling to untangle Christmas lights while dealing with patent battles. It’s like trying to juggle snow globes with one hand tied behind your back. Meanwhile, the White House holds the key to this gripping saga. Will they play Santa and reverse the commission’s decision, or will Apple find coal in its stocking? The suspense is unbearable. Move over, Netflix, we’ve got a real-life legal drama unfolding.
As the tech world holds its breath, we’re left to wonder: Will the Series 9 and Ultra 2 Apple Watches rise from the ashes like a phoenix in a licensing agreement? Or will Apple continue playing hardball, hoping the Biden administration sees them as the gold standard of innovation and reverse the order?
Read the story here:
https://www.npr.org/2023/12/18/1220125508/apple-watch-series-9-ultra-2-masimo-patent
Find the order here:
https://www.usitc.gov/system/files?file=secretary/fed_reg_notices/337/337_1276_notice10262023sgl.pdf
Nicane Mayne – The Law Fanatic
Communications Law